Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study

Figure 2

Waterfall plot regarding the change of target lesions from baseline among the 68 elderly patients with advanced NSCLC who received PD-1 inhibitor monotherapy individually (Green columns represent PR, black columns represent SD, and red column represents PD based on the best overall response).